170 related articles for article (PubMed ID: 22575025)
1. CD147 expression in advanced cutaneous squamous cell carcinoma.
Sweeny L; Dean NR; Frederick JW; Magnuson JS; Carroll WR; Desmond RA; Rosenthal EL
J Cutan Pathol; 2012 Jun; 39(6):603-9. PubMed ID: 22575025
[TBL] [Abstract][Full Text] [Related]
2. Monocarboxylate transporter 4 (MCT4) and CD147 overexpression is associated with poor prognosis in prostate cancer.
Pértega-Gomes N; Vizcaíno JR; Miranda-Gonçalves V; Pinheiro C; Silva J; Pereira H; Monteiro P; Henrique RM; Reis RM; Lopes C; Baltazar F
BMC Cancer; 2011 Jul; 11():312. PubMed ID: 21787388
[TBL] [Abstract][Full Text] [Related]
3. Co-expression of CD147/EMMPRIN with monocarboxylate transporters and multiple drug resistance proteins is associated with epithelial ovarian cancer progression.
Chen H; Wang L; Beretov J; Hao J; Xiao W; Li Y
Clin Exp Metastasis; 2010 Dec; 27(8):557-69. PubMed ID: 20658178
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of lactate/proton symporters MCT1, MCT4, and their chaperone CD147 expressions in urothelial carcinoma of the bladder.
Choi JW; Kim Y; Lee JH; Kim YS
Urology; 2014 Jul; 84(1):245.e9-15. PubMed ID: 24857275
[TBL] [Abstract][Full Text] [Related]
5. Expression of lactate/H⁺ symporters MCT1 and MCT4 and their chaperone CD147 predicts tumor progression in clear cell renal cell carcinoma: immunohistochemical and The Cancer Genome Atlas data analyses.
Kim Y; Choi JW; Lee JH; Kim YS
Hum Pathol; 2015 Jan; 46(1):104-12. PubMed ID: 25456395
[TBL] [Abstract][Full Text] [Related]
6. EGFR expression in advanced head and neck cutaneous squamous cell carcinoma.
Sweeny L; Dean NR; Magnuson JS; Carroll WR; Helman EE; Hyde SO; Desmond RL; Rosenthal EL
Head Neck; 2012 May; 34(5):681-6. PubMed ID: 21739514
[TBL] [Abstract][Full Text] [Related]
7. Prognostic Indications of Elevated MCT4 and CD147 across Cancer Types: A Meta-Analysis.
Bovenzi CD; Hamilton J; Tassone P; Johnson J; Cognetti DM; Luginbuhl A; Keane WM; Zhan T; Tuluc M; Bar-Ad V; Martinez-Outschoorn U; Curry JM
Biomed Res Int; 2015; 2015():242437. PubMed ID: 26779534
[TBL] [Abstract][Full Text] [Related]
8. Co-expression of CD147 (EMMPRIN), CD44v3-10, MDR1 and monocarboxylate transporters is associated with prostate cancer drug resistance and progression.
Hao J; Chen H; Madigan MC; Cozzi PJ; Beretov J; Xiao W; Delprado WJ; Russell PJ; Li Y
Br J Cancer; 2010 Sep; 103(7):1008-18. PubMed ID: 20736947
[TBL] [Abstract][Full Text] [Related]
9. Monocarboxylate transporters 1 and 4 are associated with CD147 in cervical carcinoma.
Pinheiro C; Longatto-Filho A; Pereira SM; Etlinger D; Moreira MA; Jubé LF; Queiroz GS; Schmitt F; Baltazar F
Dis Markers; 2009; 26(3):97-103. PubMed ID: 19597291
[TBL] [Abstract][Full Text] [Related]
10. CD147 subunit of lactate/H+ symporters MCT1 and hypoxia-inducible MCT4 is critical for energetics and growth of glycolytic tumors.
Le Floch R; Chiche J; Marchiq I; Naiken T; Ilc K; Murray CM; Critchlow SE; Roux D; Simon MP; Pouysségur J
Proc Natl Acad Sci U S A; 2011 Oct; 108(40):16663-8. PubMed ID: 21930917
[TBL] [Abstract][Full Text] [Related]
11. GLUT1, MCT1/4 and CD147 overexpression supports the metabolic reprogramming in papillary renal cell carcinoma.
Almeida LMCA; Silva R; Cavadas B; Lima J; Pereira L; Soares P; Sobrinho-Simões M; Lopes JM; Máximo V
Histol Histopathol; 2017 Oct; 32(10):1029-1040. PubMed ID: 28028797
[TBL] [Abstract][Full Text] [Related]
12. Clinically relevant HIF-1α-dependent metabolic reprogramming in oropharyngeal squamous cell carcinomas includes coordinated activation of CAIX and the miR-210/ISCU signaling axis, but not MCT1 and MCT4 upregulation.
Sáenz-de-Santa-María I; Bernardo-Castiñeira C; Secades P; Bernaldo-de-Quirós S; Rodrigo JP; Astudillo A; Chiara MD
Oncotarget; 2017 Feb; 8(8):13730-13746. PubMed ID: 28099149
[TBL] [Abstract][Full Text] [Related]
13. PGC-1alpha increases skeletal muscle lactate uptake by increasing the expression of MCT1 but not MCT2 or MCT4.
Benton CR; Yoshida Y; Lally J; Han XX; Hatta H; Bonen A
Physiol Genomics; 2008 Sep; 35(1):45-54. PubMed ID: 18523157
[TBL] [Abstract][Full Text] [Related]
14. CD147 silencing inhibits lactate transport and reduces malignant potential of pancreatic cancer cells in in vivo and in vitro models.
Schneiderhan W; Scheler M; Holzmann KH; Marx M; Gschwend JE; Bucholz M; Gress TM; Seufferlein T; Adler G; Oswald F
Gut; 2009 Oct; 58(10):1391-8. PubMed ID: 19505879
[TBL] [Abstract][Full Text] [Related]
15. CD147 and MCT1-potential partners in bladder cancer aggressiveness and cisplatin resistance.
Afonso J; Santos LL; Miranda-Gonçalves V; Morais A; Amaro T; Longatto-Filho A; Baltazar F
Mol Carcinog; 2015 Nov; 54(11):1451-66. PubMed ID: 25263481
[TBL] [Abstract][Full Text] [Related]
16. In vitro and in vivo prostate cancer metastasis and chemoresistance can be modulated by expression of either CD44 or CD147.
Hao J; Madigan MC; Khatri A; Power CA; Hung TT; Beretov J; Chang L; Xiao W; Cozzi PJ; Graham PH; Kearsley JH; Li Y
PLoS One; 2012; 7(8):e40716. PubMed ID: 22870202
[TBL] [Abstract][Full Text] [Related]
17. Tissue expression of lactate transporters (MCT1 and MCT4) and prognosis of malignant pleural mesothelioma (brief report).
Dell'Anno I; Barone E; Mutti L; Rassl DM; Marciniak SJ; Silvestri R; Landi S; Gemignani F
J Transl Med; 2020 Sep; 18(1):341. PubMed ID: 32887638
[TBL] [Abstract][Full Text] [Related]
18. Clinical impact of HAb18G/CD147 expression in esophageal squamous cell carcinoma.
Zhu S; Li Y; Mi L; Zhang Y; Zhang L; Gong L; Han X; Yao L; Lan M; Chen Z; Zhang W
Dig Dis Sci; 2011 Dec; 56(12):3569-76. PubMed ID: 21789540
[TBL] [Abstract][Full Text] [Related]
19. The prognostic value of CD147/EMMPRIN is associated with monocarboxylate transporter 1 co-expression in gastric cancer.
Pinheiro C; Longatto-Filho A; Simões K; Jacob CE; Bresciani CJ; Zilberstein B; Cecconello I; Alves VA; Schmitt F; Baltazar F
Eur J Cancer; 2009 Sep; 45(13):2418-24. PubMed ID: 19628385
[TBL] [Abstract][Full Text] [Related]
20. Prognostic markers in metastatic cutaneous squamous cell carcinoma of the head and neck.
Hirshoren N; Danne J; Dixon BJ; Magarey M; Kleid S; Webb A; Tiong A; Corry J; Gyorki D
Head Neck; 2017 Apr; 39(4):772-778. PubMed ID: 28199044
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
